Description
We are seeking a Senior Clinical Strategy Leader to serve as the senior clinical strategy leader on the MDT core quad, acting as a full strategic partner to the Medicine Development Leader (MDL) and representing Clinical Development in portfolio, governance, and investment decisions.
The successful candidate will be accountable for strategic outcomes across the asset, with study-level delivery, including design, execution, and data generation, led by Senior Scientists and programme teams within the CDL’s strategic direction.
Key Responsibilities:
- Enterprise Clinical Strategy and Governance
- Clinical Development Plan and Benefit–Risk Leadership
- Scientific Leadership and External Engagement
- People Leadership and Capability Development
The Senior Clinical Strategy Leader will serve as the recognised clinical authority and visible leader for the asset, ensuring its clinical vision, scientific identity, and development trajectory are clearly understood and advanced across the organisation.
The ideal candidate will have:
- MD, PharmD, PhD, or equivalent advanced degree required (MD strongly preferred)
- Minimum 10 years’ pharmaceutical or relevant scientific, medical, or clinical experience, with at least 7 years in oncology clinical development
- Evidenced strong disease area knowledge in GU malignancies (prostate and/or bladder cancer)
- Demonstrated experience operating at the asset, portfolio, or enterprise level, including governance and investment decision-making
- In-depth knowledge of GCP, ICH, FDA, EMA, NICE, and relevant regulatory frameworks
- Proven ability to lead and influence cross-functional teams in complex matrix environments
- Strong understanding of clinical development, oncology therapeutic landscapes, and drug approval processes
- Experience leveraging data, advanced analytics, or emerging technologies to inform clinical decision-making